- Mutation Status Drives PARP Inhibitor Investigation and Treatment in mCRPC.
- Wahner A.
- OncLive. 2023 Feb 1.
- Commentary
- Free Full Text
- Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review.
- Chatterji S, Krzoska E, Thoroughgood CW, Saganty J, Liu P, Elsberger B, Abu-Eid R, Speirs V.
- Lancet Oncol. 2023 Feb;24(2):e74-e85. doi: 10.1016/S1470-2045(22)00633-7.
- PMID: 36725152
- PubMed abstract
- Source abstract
- Review
•• Podcast:
In conversation with... Valerie Speirs.